Quarterly report pursuant to Section 13 or 15(d)

Receivables and Other Assets - Other Assets (Details)

v3.23.3
Receivables and Other Assets - Other Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Receivables [Abstract]            
Restricted cash $ 67,910 $ 35,145 $ 67,910 $ 35,145 $ 34,673 $ 0
Operating lease, right-of-use asset, statement of financial position [Extensible Enumeration] Total   Total   Total  
Finance lease, right-of-use asset, statement of financial position [Extensible Enumeration] Total   Total   Total  
Right-of-use assets, net $ 25,650   $ 25,650   $ 26,422  
Investment in unconsolidated joint venture 14,124   14,124   15,824  
Deferred costs, net 8,444   8,444   4,619  
Prepaid expenses 2,203   2,203   1,305  
Derivative assets 986   986   6,308  
Other assets, net 1,073   1,073   1,063  
Total 120,390   120,390   90,214  
Amortization expense for below market right-of-use, less than 100 100 100 100    
Finance lease, right-of-use 9,000   9,000   9,000  
Operating lease, right-of-use 9,900   9,900   10,600  
Below market lease, right-of-use asset 6,700   6,700   6,800  
Line of Credit Facility [Line Items]            
Amortization of deferred financing costs     3,041 3,295    
Deferred offering costs 600   600   500  
Credit facility revolver | Line of Credit            
Line of Credit Facility [Line Items]            
Amortization of deferred financing costs 800 $ 500 1,800 $ 1,600    
Accumulated amortization of deferred costs $ 4,300   4,300   $ 2,500  
Deferred costs capitalized     $ 5,600